The Cancer in Our Genes International Databank (CGIP) is Here! Participate Now!
The VHL Alliance announces a new competitive research grant cycle with a total funding of $150,000.
To date, the VHL Alliance has awarded over $1.4 million to support VHL research. See details
Increase in Life Expectancy: link to article
Thanks to advances in medical research, clinical guidelines for screening, diagnosis, and treatment have been developed which have contributed to extending VHL patient life expectancy by over 16 years! Our hope is that through continued research efforts, we will find ways of keeping tumors from forming, or at least keeping them small, and reduce the need for surgical intervention.
Updated Compilation of VHL Gene Mutations and associated patient phenotypes: Provided by Dr. Rachel Giles
If information from this database is used for publication, please cite the following:
Genetic Analysis of von Hippel-Lindau Disease. Nordstrom-O’Brien M, van der Luijt RB, van Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, van Brussel A, Voest EE, Giles RH. Hum Mutat. 2010 May;31(5):521-37. doi: 10.1002/humu.21219. PMID: 20151405